(INNS)
SABESTOMIG(INNC)
IMMUNOGLOBULIN G1-KAPPA/LAMBDA, ANTI-[HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD1, PD-1, CD279) AND HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2, T CELL IMMUNOGLOBULIN AND MUCIN DOMAINS FAMILY MEMBER 3, TIM3, TIM-3, TIMD3, CD366)], HUMANIZED AND HOMO SAPIENS MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT; GAMMA1 HEAVY CHAIN ANTI-PDCD1 HUMANIZED (1-452) [VH HUMANIZED (HOMO SAPIENS IGHV3-48*01 (92.9%) -(IGHD) - IGHJ4*01 (93.3%) L123>T (117), CDR-IMGT [8.8.15] (26- 33.51-58.97-111)) (1-122) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, G1V39 CH2 F1.3, E1.2, S116, G1V33 CH3 S22, A24, V86 (HOLE) (CH1 R120 (219) (123-220), HINGE 1-15 (221-235), CH2 L1.3>F (239), L1.2>E (240), P116>S (336) (236-345), CH3 E12 (361), M14 (363), Y5>C (354), T22>S (371), L24>A (373), Y86>V (412) (346-450), CHS (451-452)) (123-452)], (225- 219')-DISULFIDE WITH KAPPA LIGHT CHAIN ANTI-PDCD1...PROPOSED INN: LIST 128, RECOMMENDED INN: LIST 90(WHO)
SABESTOMIGUM(INN)